Philips publishes its Annual Report 2025

February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips' Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026.

GlobeNewsWire • Feb 19, 2026

Why Royal Philips (PHG) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 19, 2026

Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Feb 17, 2026

Philips introduces InkSpace Imaging's Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort

February 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians.

GlobeNewsWire • Feb 12, 2026

Philips Posts Earnings in Q4, Revenues Increase Y/Y, Shares Dip

PHG swings to Q4 profit as comparable sales jump 7% and orders rise, but shares fall despite double-digit EBITA growth and 2026 outlook.

Zacks Investment Research • Feb 11, 2026

SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments

February 11, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the research consortium is coordinated by Philips, together with Erasmus MC as academic lead, and will combine advanced medical imaging and minimally invasive techniques to transform treatment of bleeding and tumors in the brain Five-year research program with total budget of EUR 38.4 million includes eight clinical studies to validate technical solutions for minimally invasive neurosurgery Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the SEISMIC research consortium, coordinated by Philips, together with Erasmus MC as academic lead, has been awarded funding from the Innovative Health Initiative (IHI) to transform neurosurgery through the seamless integration of minimally invasive surgical techniques and advanced imaging technologies. The EUR 23.5 million public funding will be complemented by EUR 14.9 million in in-kind contributions and additional resources from industry partners, supporting a five-year research and innovation program that also includes eight clinical studies.

GlobeNewsWire • Feb 11, 2026

Philips Proposes Extension of CEO's Tenure After Guiding For Higher Profitability

Roy Jakobs has headed Philips since October 2022 and the company said it would put his re-appointment to shareholders later this year.

WSJ • Feb 10, 2026

Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript

Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 10, 2026

Philips proposes to re-appoint CEO Roy Jakobs

February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth.

GlobeNewsWire • Feb 10, 2026

Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day

Amsterdam, February 10, 2026 Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4 Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in Q4 Income from operations was EUR 1,424 million in 2025; EUR 540 million in Q4 Adjusted EBITA margin increased 80 basis points to 12.3% of sales in 2025; up 160 basis points to 15.1% in Q4 Operating cash flow of EUR 1,172 million in 2025; EUR 1,391 million in Q4 Free cash flow of EUR 512 million in 2025; EUR 1,200 million in Q4 Productivity savings of EUR 0.8 billion in 2025; delivered 2023-2025 target of EUR 2.5 billion Proposed 2025 dividend of EUR 0.85 per share, in shares or cash at the option of the shareholder Outlook for 2026 published Capital Markets Day Philips sets out plan to drive profitable growth to deliver sustainable value, including new, integrated 2030 Impact Ambitions. Plan comprises three pillars: segment-specific growth strategies, innovation as a key growth driver and continued disciplined execution Philips publishes 2026-2028 financial targets, including mid-single-digit comparable sales growth CAGR over the period and mid-teens Adjusted EBITA margin in 2028 Roy Jakobs, CEO of Royal Philips: “In 2025, we delivered on our commitments as we scaled better care for more people.

GlobeNewsWire • Feb 10, 2026